Lexaria Bioscience Announces Partnership with Altria to Fund Research and Development of DehydraTECH™ Technology for Oral Nicotine
Lexaria Nicotine LLC and a subsidiary of Altria Group, Inc. have entered into a definitive investment agreement. The Altria investment will fund research on regulatory compliant, oral forms of nicotine…
Lexaria Bioscience Expands Staff, Issues Options
Kelowna, British Columbia – December 7, 2018 – Lexaria Bioscience Corp. (OTCQX: LXRP) (CSE: LXX) (the “Company” or “Lexaria”), a drug delivery platform innovator, announces the following updates. The Company…
Lexaria Bioscience Submits Application to Health Canada for Research License and Appoints Chief Legal Officer
Kelowna, British Columbia – November 26, 2018 – Lexaria Bioscience Corp. (OTCQX: LXRP) (CSE: LXX) (the “Company” or “Lexaria”), a drug delivery platform innovator, announces it has submitted a Health…
Lexaria Bioscience Launches ChrgD+
Kelowna, British Columbia – November 13, 2018 – Lexaria Bioscience Corp. (OTCQX: LXRP) (CSE: LXX) (the “Company” or “Lexaria”), a drug delivery platform innovator, announces the launch of ChrgD+, a…
Lexaria Bioscience Announces Increased Size and Closing of Private Placement
Kelowna, British Columbia – October 31, 2018 – Lexaria Bioscience Corp. (OTCQX: LXRP) (CSE: LXX) (the “Company” or “Lexaria”), a drug delivery platform innovator, announces that due to strong demand…
Lexaria Bioscience Receives Two New Granted Patents
Kelowna, British Columbia – October 18, 2018 – Lexaria Bioscience Corp. (OTCQX: LXRP) (CSE: LXX) (the “Company” or “Lexaria”), a drug delivery platform innovator, announces it has been granted two…
Lexaria Bioscience Arranges Private Placement Financing to Fund New Laboratory
Kelowna, British Columbia – October 16, 2018 – Lexaria Bioscience Corp. (OTCQX: LXRP) (CSE: LXX) (the “Company” or “Lexaria”), a drug delivery platform innovator, announces it has arranged a non-brokered private…
Lexaria Bioscience Creates and Brands Subsidiary Companies
Kelowna, British Columbia – October 10, 2018 – Lexaria Bioscience Corp. (OTCQX: LXRP) (CSE: LXX) (the “Company” or “Lexaria”), a drug delivery platform innovator, is pleased to announce it has…
Lexaria Files New Patent Application for Delivery of Tobacco-Derived Products
Kelowna, British Columbia – September 28, 2018 – Lexaria Bioscience Corp. (OTCQX: LXRP) (CSE: LXX) (the “Company” or “Lexaria”), a drug delivery platform innovator, announces the filing of a new…
Lexaria Receives Three Patent Grants and Two Notices of Allowance
Kelowna, British Columbia – September 7, 2018 – Lexaria Bioscience Corp. (OTCQX: LXRP) (CSE: LXX) (the “Company” or “Lexaria”), a drug delivery platform innovator, announces strategic additions to its patent…